wIRA: hyperthermia as a treatment option for intracellular bacteria, with special focus on Chlamydiae and Mycobacteria

References

• MacLean RC, San Millan A. The evolution of antibiotic resistance. Science. 2019;365(6458):1082–1083.
   PubMed Web of Science ®Google Scholar
• Chopra R, Levi-Polyachenko N, Smeltzer MS. Introduction to the special issue on thermal therapy and infectious diseases. Int J Hyperthermia. 2018;34(2):133–134.
   PubMed Web of Science ®Google Scholar
• Gazel D, Yılmaz M. Are infectious disease and microbiology new fields for thermal therapy research? Int J Hyperthermia. 2018;34(7):918–924.
   PubMed Web of Science ®Google Scholar
• Ibelli T, Templeton S, Levi-Polyachenko N. Progress in utilizing hyperthemia for mitigating bacterial infections. Int J Hyperthermia. 2018;34(2):144–156.
   PubMed Web of Science ®Google Scholar
• Wardlow R, Bing C, VanOsdol J, et al. Targeted antibiotic delivery using low temperature-sensitive liposomes and magnetic resonance-guided high-intensity focused ultrasound hyperthermia. Int J Hyperthermia. 2016;32(3):254–264.
   PubMed Web of Science ®Google Scholar
• Ricker EB, Aljaafari H, Bader TM, et al. Thermal shock susceptibility and regrowth of Pseudomonas aeruginosa biofilms. Int J Hyperthermia. 2018;34(2):168–176.
   PubMed Web of Science ®Google Scholar
• Wardlow R, Sahoo K, Dugat D, et al. High intensity focused ultrasound (HIFU) heating improves perfusion and antimicrobial efficacy in mouse Staphylococcus abscess. Ultrasound Med. Biol. 2018; 44(4):909–914.
   PubMed Web of Science ®Google Scholar
• Hartel M, Illing P, Mercer JB, et al. Therapy of acute wounds with water-filtered infrared-A (wIRA). GMS Krankenhhyg Interdiszip. 2007;2(2):Doc53.
   PubMedGoogle Scholar
• Hellige G, Becker G, Hahn G. Temperaturverteilung und Eindringtiefe wassergefilterter Infrarot-A-Strahlung. In Vaupel P, Krüger W, editors. Wärmetherapie mit wassergefilterter Infrarot-A-Strahlung. Grundlagen und Anwendungsmöglichkeiten. Stuttgart: Hippokrates Verlag; 1995.
   Google Scholar
• Vaupel P., Krüger W. (Eds.). Wärmetherapie mit wassergefilterter Infrarot-A-Strahlung. Stuttgart: Hippokrates; 1992.
   Google Scholar
• Vaupel P, Kelleher DK, Krüger W. Water-filtered infrared-A-radiation: a novel technique to heat superficial tumors. Strahlenther. Onkol. 1992;168:633–639.
   PubMedGoogle Scholar
• Vaupel P, Piazena H, Müller W, et al. Biophysical and photobiological basics of water-filtered infrared-A hyperthermia of superficial tumors. Int J Hyperthermia. 2018;35(1):26–36.
   PubMed Web of Science ®Google Scholar
• Jung T, Höhn A, Lau AM, et al. An experimental setup for the measurement of nonthermal effects during water-filtered infrared a-irradiation of mammalian cell cultures. Photochem Photobiol. 2012;88:371–380 doi: 10.1111/j.1751-1097.2011.01072.x.
   PubMed Web of Science ®Google Scholar
• Hartel M, Hoffmann G, Wente MN, et al. Randomized clinical trial of the influence of local water-filtered infrared A irradiation on wound healing after abdominal surgery. Br J Surg. 2006;93(8):952–960.
   PubMed Web of Science ®Google Scholar
• Hoffmann G. Principles and working mechanisms of water-filtered infrared-A (wIRA) in relation to wound healing. GMS Krankenhhyg. Interdiszip. 2007;2(2):Doc54.
   PubMedGoogle Scholar
• Künzli BM, Liebl F, Liebl P, et al. Impact of preoperative local water-filtered infrared a irradiation on postoperative wound healing: a randomized patient-and observer- blinded controlled clinical trial). Ann Surg. 2013;258:887–894 doi: 10.1097/SLA.0000000000000235.
   PubMed Web of Science ®Google Scholar
• Von Felbert V, Schumann H, Mercer JB, et al. Therapy of chronic wounds with water-filtered infrared-A (wIRA). GMS Krankenhyg. Interdiszip. 2007;2(2):Doc52.
   Google Scholar
• Reilly J, Twaddle S, McIntosh J, et al. An economic analysis of surgical wound infection. J Hosp Infect. 2001;49(4):245–249.
   PubMed Web of Science ®Google Scholar
• Weber WP, Marti WR, Zwahlen M, et al. The timing of surgical antimicrobial prophylaxis. Ann Surg. 2008;247(6):918–926.
   PubMed Web of Science ®Google Scholar
• Plattner O, Akça O, Herbst F, et al. The influence of 2 surgical bandage systems on wound tissue oxygen tension. Arch Surg. 2000;135(7):818–822.
   PubMedGoogle Scholar
• Buggy DJ, Doherty WL, Hart EM, et al. Postoperative wound oxygen tension with epidural or intravenous analgesia: a prospective, randomized, single-blind clinical trial. Anesthesiology. 2002;97(4):952–958.
   PubMed Web of Science ®Google Scholar
• Hopf HW, Hunt TK, West JM, et al. Wound tissue oxygen tension predicts the risk of wound infection in surgical patients. Arch Surg. 1997;132(9):997–1004.
   PubMed Web of Science ®Google Scholar
• Khan AA, Banwell PE, Bakker MC, et al. Topical radiant heating in wound healing: an experimental study in a donor site wound model. Int Wound J. 2004;1(4):233–240.
   PubMedGoogle Scholar
• Hoffmann G, Hartel M, Mercer JB. Heat for wounds - water-filtered infrared-A (wIRA) for wound healing - a review. Ger Med Sci. 2016;14:Doc08.
   PubMedGoogle Scholar
• Melling AC, Ali B, Scott EM, et al. Effects of preoperative warming on the incidence of wound infection after clean surgery: a randomised controlled trial. Lancet. 2001;358(9285):876–880.
   PubMed Web of Science ®Google Scholar
• Applegate LA, Scaletta C, Panizzon R, et al. Induction of the putative protection protein ferritin by infrared radiation: implications in skin repair. Int J Mol Med. 2000;5:247–251.
   PubMed Web of Science ®Google Scholar
• Danno K, Mori N, Toda K, et al. Near-infrared irradiation stimulates cutaneous wound repair: laboratory experiments on possible mechanisms. Photoderm Photoimm Photomed. 2001;17(6):261–265.
   PubMed Web of Science ®Google Scholar
• Wysocki S. Gewebespiegel verschiedener Antibiotika beim Menschen. Infection. 1976;4(S2):S115–S122.
   PubMedGoogle Scholar
• Aljasir A, Pierson T, Hoffmann G, et al. Management of donor site infections in split-thickness skin graft with water-filtered infrared-A (wIRA). GMS Interdiscip Plast Reconstr Surg DGPW. 2018;7:Doc03.
   PubMed Web of Science ®Google Scholar
• Notter M, Piazena H, Vaupel P. Hypofractionated re-irradiation of large-sized recurrent breast cancer with thermography-controlled, contact-free water-filtered infra-red-A hyperthermia: a retrospective study of 73 patients. Int J Hyperth. 2017;33:227–236. doi: 10.1080/02656736.2016.1235731
   PubMed Web of Science ®Google Scholar
• Piazena H, Müller W, Pendl W, et al. Thermal field formation during wIRA-hyperthermia: temperature measurements in skin and subcutis of piglets as a basis for thermotherapy of superficial tumors and local skin infections caused by thermosensitive microbial pathogens. Int J Hyperthermia. 2019;36(1):937–951.
   Web of Science ®Google Scholar
• Junghanss T, Johnson RC, Pluschke G, Mycobacterium ulcerans disease. In Farrar J, Hotez PJ, Junghanss T, Kang G, Lalloo D, White NJ, editors. Manson’s tropical diseases. 23rd ed. Edinburgh: Saunders, 519–531; 2014.
   Google Scholar
• Röltgen K, Pluschke G. Buruli ulcer: history and disease burden. In Röltgen K, Pluschke G, editors. Buruli ulcer. Cham, Switzerland: Springer Nature. 2019.
   Google Scholar
• MacCallum P, Tolhurst JC, Buckle G, et al. A new mycobacterial infection in man. J Pathol. 1948;60(1):93–122.
   Web of Science ®Google Scholar
• Eddyani M, Portaels F. Survival of Mycobacterium ulcerans at 37 degrees C. Clin Microbiol Infect. 2007;13(10):1033–1035.
   PubMed Web of Science ®Google Scholar
• Feldman WH, Karlson AG, Herrick JF. Mycobacterium ulcerans; pathogenesis of infection in mice, including determinations of dermal temperatures. Am J Pathol. 1957;33(6):1163–1179.
   PubMed Web of Science ®Google Scholar
• Guenin-Macé L, Ruf MT, Pluschke G, et al. Mycolactone: more than just a cytotoxin. In Röltgen K, Pluschke G, editors. Buruli ulcer. Springer Nature; 2019.
   Google Scholar
• Hall B, Simmonds R. Pleiotropic molecular effects of the Mycobacterium ulcerans virulence factor mycolactone underlying the cell death and immunosuppression seen in Buruli ulcer. Biochem Soc Trans. 2014;42(1):177–183.
   PubMed Web of Science ®Google Scholar
• Ruf MT, Steffen C, Bolz M, et al. Infiltrating leukocytes surround early Buruli ulcer lesions, but are unable to reach the mycolactone producing mycobacteria. Virulence. 2017;8(8):1918–1926.
   PubMed Web of Science ®Google Scholar
• Scherr N, Pluschke G. Buruli ulcer. In Swinney D, Pollastri M, editors. Neglected tropical diseases: drug discovery and development. Weinheim, Germany: Wiley‐VCH Verlag GmbH; 2019.
   Google Scholar
• Omansen TF, van der Werf TS, Phillips RO. Antimicrobial treatment of Mycobacterium ulcerans infection. In Röltgen K, Pluschke G, editors. Buruli ulcer. Cham, Switzerland: Springer Nature; 2019.
   Google Scholar
• Cornet L, Richard-Kadio M, N’Guessan HA, et al. Treatment of Buruli’s ulcers by excision-graft. Bull Soc Pathol Exot. 1992;85(5):355–358.
   PubMed Web of Science ®Google Scholar
• Teelken MA, Stienstra Y, Ellen DE, et al. Buruli ulcer: differences in treatment outcome between two centres in Ghana. Acta Trop. 2003;88(1):51–56.
   PubMed Web of Science ®Google Scholar
• Ackumey MM, Gyapong M, Pappoe M, et al. Socio-cultural determinants of timely and delayed treatment of Buruli ulcer: implications for disease control. Infect Dis Poverty. 2012;1(1):6.
   PubMed Web of Science ®Google Scholar
• WHO - Provisional guidance on the role of specific antibiotics in the management of Mycobacterium ulcerans disease (Buruli ulcer). 2004. Available from: https://apps.who.int/iris/handle/10665/68839.
   Google Scholar
• WHO - Report from the Meeting of the Buruli ulcer Technical Advisory Group. [cited Mar 2017]. Available from: http://www.who.int/neglected_diseases/events/WHO_BU_TAG_2017_report.pdf.
   Google Scholar
• Scherr N, Bieri R, Thomas SS, et al. Targeting the Mycobacterium ulcerans cytochrome bc1:aa3 for the treatment of Buruli ulcer. Nat Commun. 2018;9(1):5370.
   PubMed Web of Science ®Google Scholar
• Asiedu K, Scherpbier R, Raviglione M. (Eds.). Buruli ulcer: Mycobacterium ulcerans infection. Yamoussoukro Declaration of Buruli Ulcer. WHO – Department of disease control, prevention and eradication. 2000.
   Google Scholar
• Bratschi MW, Bolz M, Grize L, et al. Primary cultivation: factors affecting contamination and Mycobacterium ulcerans growth after long turnover time and clinical specimens. BMC Infect Dis. 2014;14(1):636.
   PubMed Web of Science ®Google Scholar
• Scherr N, Röltgen K, Witschel M, et al. Screening of antifungal azole drugs and agrochemicals with an adapted Alamar Blue-based assay demonstrates antibacterial activity of croconazole against Mycobacterium ulcerans. Antimicrob Agents Chemother. 2012;56(12):6410–6413.
   PubMed Web of Science ®Google Scholar
• Van Rhoon G. Is CEM43 still a relevant thermal dose parameter for hyperthermia treatment monitoring?. Int J Hyperthermia. 2016;32(1):50–62.
   PubMed Web of Science ®Google Scholar
• Schütte D, Pluschke G. Immunosuppression and treatment-associated inflammatory response in patients with Mycobacterium ulcerans infection (Buruli ulcer). Expert Opin Biol Ther. 2009;9(2):187–200.
   PubMed Web of Science ®Google Scholar
• Schütte D, Umboock A, Pluschke G. Phagocytosis of Mycobacterium ulcerans in the course of rifampicin and streptomycin chemotherapy in Buruli ulcer lesions. Br J Dermatol. 2009;160(2):273–283.
   PubMed Web of Science ®Google Scholar
• Meyers WM, Shelly WM, Connor DH. Heat treatment of Mycobacterium ulcerans infections without surgical excision. Am J Trop Med Hyg. 1974;23(5):924–929.
   PubMed Web of Science ®Google Scholar
• Braxmeier S, Hellmann M, Beck A, et al. Phase change material for thermotherapy of Buruli ulcer: modelling as an aid to implementation. J Med Eng Technol. 2009;33(7):559–566.
   PubMedGoogle Scholar
• Junghanss T, Um Boock A, Vogel M, et al. Phase change material for thermotherapy of Buruli ulcer: a prospective observational single centre proof-of-principle trial. PLoS Negl Trop Dis. 2009;3(2):e380.
   PubMed Web of Science ®Google Scholar
• Vogel M, Bayi PF, Bratschi MW, et al. Local heat application for the treatment of Buruli ulcer: results of a phase II open label single Center non comparative clinical trial. Clin Infect Dis. 2016;62(3) :342–350.
   PubMed Web of Science ®Google Scholar
• Ruf MT, Bolz M, Vogel M, et al. Spatial distribution of Mycobacterium ulcerans in Buruli ulcer lesions: implications for laboratory diagnosis. PLoS Negl Trop Dis. 2016;10(6):e0004767.
   PubMed Web of Science ®Google Scholar
• WHO - Trachoma. [cited 2017 Mar 31]. Available from: http://www.who.int/topics/trachoma/en/
   Google Scholar
• Wright HR, Turner A, Taylor HR. Trachoma. Lancet. 2008;371(9628):1945–1954.
   PubMed Web of Science ®Google Scholar
• Leonard CL, Borel N. Chronic chlamydial diseases: from atherosclerosis to urogenital infections. Curr Clin Micro Rpt. 2014;1(3-4):61–72.
   Google Scholar
• Wolle MA, West SK. Ocular Chlamydia trachomatis infection: elimination with mass drug administration. Expert Rev Anti Infect Ther. 2019;17(3):189–200.
   PubMed Web of Science ®Google Scholar
• Burton MJ, Mabey D. The global burden of trachoma: a review. PLoS Negl Trop Dis. 2009;3(10):e460.
   PubMed Web of Science ®Google Scholar
• Hu VH, Holland MJ, Burton MJ. Trachoma: protective and pathogenic ocular immune responses to Chlamydia trachomatis. PLoS Negl Trop Dis. 2013;7(2):e2020.
   PubMed Web of Science ®Google Scholar
• Taylor HR, Burton MJ, Haddad D, et al. Trachoma. Lancet. 2014;384(9960):2142–2152.
   PubMed Web of Science ®Google Scholar
• Ho DK, Sawicki C, Grassly N. Antibiotic resistance in Streptococcus pneumoniae after azithromycin distribution for trachoma. J Trop Med. 2015;2015:1–8.
   Web of Science ®Google Scholar
• O'Brien KS, Emerson P, Hooper PJ, et al. Antimicrobial resistance following mass azithromycin distribution for trachoma: a systematic review. Lancet Infect Dis. 2019;19(1):e14–e25.
   PubMed Web of Science ®Google Scholar
• Brunham RC, Rekart ML. The arrested immunity hypothesis and the epidemiology of Chlamydia control. Sex Transm Dis. 2008;35(1):53–54.
   PubMed Web of Science ®Google Scholar
• Wyrick PB. Chlamydia trachomatis persistence in vitro: an overview. J Infect Dis. 2010;201(S2):88–95.
   Web of Science ®Google Scholar
• Bavoil PM. What’s in a word: the use, misuse, and abuse of the word “persistence” in Chlamydia biology. Front Cell Infect Microbiol. 2014;4:27.
   PubMed Web of Science ®Google Scholar
• Lavett DK, Lansingh VC, Carter MJ, et al. Will the SAFE strategy be sufficient to eliminate trachoma by 2020? Puzzlements and possible solutions. Sci World J. 2013;2013:1–18.
   Web of Science ®Google Scholar
• Mukhopadhyay S, Miller RD, Sullivan ED, et al. Protein expression profiles of Chlamydia pneumoniae in models of persistence versus those of heat shock stress response. Infect Immun. 2006;74(7):3853–3863.
   PubMed Web of Science ®Google Scholar
• Hogan RJ, Mathews SA, Mukhopadhyay S, et al. Chlamydial persistence: beyond the biphasic paradigm. Infect Immun. 2004;72(4):1843–1855.
   PubMed Web of Science ®Google Scholar
• Marti H, Koschwanez M, Pesch T, et al. Water-filtered infrared A irradiation in combination with visible light inhibits acute chlamydial infection. PLoS One. 2014;9(7):e10223.
   Web of Science ®Google Scholar
• Marti H, Blenn C, Borel N. The contribution of temperature, exposure intensity and visible light to the inhibitory effect of irradiation on acute chlamydial infection. J Photochem Photobiol B. 2015;153:324–333.
   PubMed Web of Science ®Google Scholar
• Rahn C, Marti H, Frohns A, et al. Water-filtered infrared A reduces chlamydial infectivity in vitro without causing ex vivo eye damage in pig and mouse models. J Photochem Photobiol B. 2016;165:340–350.
   PubMed Web of Science ®Google Scholar
• Kuratli J, Pesch T, Marti H, et al. Water filtered infrared A and visible light (wIRA/VIS) irradiation reduces Chlamydia trachomatis infectivity independent of targeted cytokine inhibition. Front Microbiol. 2018;9:2757.
   PubMed Web of Science ®Google Scholar
• Kuratli J, Borel N. Perspective: Water-filtered infrared-A-radiation (wIRA) - Novel treatment options for chlamydial infections? Front Microbiol. 2019;10:1053.
   PubMed Web of Science ®Google Scholar
• Inic-Kanada A, Stojanovic M, Barisani-Asenbauer T, et al. Water-filtered Infrared A and visible light (wIRA/VIS) treatment reduces chlamydial load and pathology score in a guinea pig model of inclusion conjunctivitis. Swiss Society for Microbiology (SGM, SSM) Annual Meeting 2019, Zurich, 2019.
   Google Scholar
• Belij-Rammerstorfer S, Inic-Kanada A, Stojanovic M, et al. Infectious dose and repeated infections are key factors influencing immune response characteristics in guinea pig ocular chlamydial infection. Microbes Infect. 2016;18(4):254–262.
   PubMed Web of Science ®Google Scholar
• Rank RG, Whittum-Hudson JA. Animal models for ocular infections. Methods Enzymol. 1994;235:69–83.
   PubMed Web of Science ®Google Scholar
• Kenrick CJ, Alloo SS. The limitation of applying heat to the external lid surface: a case of recalcitrant meibomian gland dysfunction. Case Rep Ophthalmol. 2017;8(1):7–12.
   PubMed Web of Science ®Google Scholar
• West SK, Moncada J, Munoz B, et al. Is there evidence for resistance of ocular Chlamydia trachomatis to azithromycin after mass treatment for trachoma control?. J Infect Dis. 2014;210(1):65–71.
   PubMed Web of Science ®Google Scholar
• Nadimpalli M, Delarocque-Astagneau E, Love DC, et al.,; Bacterial Infections and antibiotic-Resistant Diseases among Young children in low-income countries (BIRDY) Study Group. Combating global antibiotic resistance: emerging one health concerns in lower- and middle-income countries. Clin Infect Dis. 2018;66(6):963–969.
   PubMed Web of Science ®Google Scholar
• Mabey D, Hu V, Bailey RL, et al. Towards a safe and effective chlamydial vaccine: lessons from the eye. Vaccine. 2014;32(14):1572–1578.
   PubMed Web of Science ®Google Scholar
• Hydrosun – Healing derived from nature. [cited 2019 Dec 12]. Available from: https://www.hydrosun.de/en
   Google Scholar
• Ouedraogo AS, Jean Pierre H, Bañuls AL, et al. Emergence and spread of antibiotic resistance in West Africa: contributing factors and threat assessment. Med Sante Trop. 2017;27(2):147–154.
   PubMed Web of Science ®Google Scholar
• Rapoza PA, Tahija SG, Carlin JP, et al. Effect of interferon on a primary conjunctival epithelial cell model of trachoma. Invest Ophthalmol Vis Sci. 1991;32(11):2919–2923.
   PubMed Web of Science ®Google Scholar
• Bobo L, Novak N, Mkocha H, et al. Evidence for a predominant proinflammatory conjunctival cytokine response in individuals with trachoma. Infect Immun. 1996;64(8):3273–3279.
   PubMed Web of Science ®Google Scholar
• Aronson NE, Wortmann GW, Byrne WR, et al. randomized controlled trial of local heat therapy versus intravenous sodium stibogluconate for the treatment of cutaneous Leishmania major infection. PLoS Negl Trop Dis. 2010;94(3):e628.
   PubMed Web of Science ®Google Scholar
• WHO - Skin diseases: integrated treatment to promote public health benefits. [cited 2017 Mar 31]. Available from: http://www.who.int/neglected_diseases/news/Skin_diseases_integrated_treatment/en/.
   Google Scholar